Title : Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis.

Pub. Date : 2015

PMID : 26251572






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Treatment with the combination of olmesartan medoxomil and amlodipine besylate led to a significant reduction in atherosclerotic lesion size in ApoE(-/-) mice (olmesartan medoxomil/amlodipine besylate: 122,277+-6,795 mum(2), number [n]=14; versus control: 177,502+-10,814 mum(2), n=9; P<0.001). olmesartan apolipoprotein E Mus musculus